Endocrine Abstracts

Introduction: Teriparatide is an osteoanabolic agent approved for the treatment of osteoporosis in postmenopausal women, in men with increased fracture risk, and in glucocorticoid-induced osteoporosis. The aim of this study was to evaluate the real-world use and efficacy of teriparatide.Patients and Methods: We retrospectively assessed all patients with available data, who received teriparatide at Leeds Teaching Hospital...